Nephron Initiates CareDx at Hold Rating With $15 Price Target
Twist Bioscience Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Verastem (VSTM), HilleVax, Inc (HLVX) and Schrodinger (SDGR)
Jefferies Initiates Recursion Pharmaceuticals at Hold With $8 Price Target
Schrodinger Analyst Ratings
Twist Bioscience Analyst Ratings
Nurix Therapeutics Analyst Ratings
Intellia Therapeutics Analyst Ratings
Canaccord Genuity Maintains Buy on Intellia Therapeutics, Maintains $73 Price Target
Ionis Pharmaceuticals Analyst Ratings
CRISPR Therapeutics Analyst Ratings
Recursion Pharmaceuticals Analyst Ratings
Intellia Therapeutics Analyst Ratings
Intellia Therapeutics Analyst Ratings
HC Wainwright & Co. Maintains Buy on Nurix Therapeutics, Raises Price Target to $26
Nurix Therapeutics Analyst Ratings
CRISPR Therapeutics Analyst Ratings
Ionis Pharmaceuticals Analyst Ratings
Twist Bioscience Analyst Ratings
Nurix Therapeutics Analyst Ratings